Precision BioSciences (FRA:PBS0) Inventories, Finished Goods: €0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PBS0 Precision BioSciences Inc FRA:PBS0
50 GF Score
Price €5.73
GF Value €1.45
! 4 Warning Signs
View Full Analysis

What is Precision BioSciences Inventories, Finished Goods?

Precision BioSciences FRA:PBS0 -3.21% 50 Inventories, Finished Goods is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:PBS0 with a GF Score™ of 50/100 and a GF Value™ of €1.45. The stock has 4 warning signs investors should review.

Precision BioSciences Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision BioSciences Inventories, Finished Goods Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Precision BioSciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:PBS0
50GF Score
Precision BioSciences Inc FRA:PBS0
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision BioSciences Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €0.00 Mil mean?
Precision BioSciences (FRA:PBS0) has a Inventories, Finished Goods of €0.00 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Precision BioSciences and its competitors.
Is Precision BioSciences' Inventories, Finished Goods too high?
Precision BioSciences' current Inventories, Finished Goods is €0.00 Mil. Overall, Precision BioSciences has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Precision BioSciences' Inventories, Finished Goods compare to NERV and VYGR?
Precision BioSciences' Inventories, Finished Goods of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Precision BioSciences and its competitors. Precision BioSciences's current Inventories, Finished Goods is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision BioSciences stock overvalued right now?
Precision BioSciences (FRA:PBS0) has a current Inventories, Finished Goods of €0.00 Mil. The stock's GF Value™ is €1.45, compared to a current price of €5.73 — trading 295.2% above its estimated fair value. The current Inventories, Finished Goods is €0.00 Mil. Precision BioSciences' overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Precision BioSciences (FRA:PBS0), the current Inventories, Finished Goods is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (FRA:PBS0) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of €5.73 is trading 295.2% above its estimated GF Value™ of €1.45.

Key valuation signals for FRA:PBS0:

  • Inventories, Finished Goods: €0.00 Mil
  • GF Value™: €1.45 vs. price of €5.73 (295.2% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the FRA:PBS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Precision BioSciences Business Description

Other Exchanges DTIL:USAPBS0:Germany
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
50GF Score

Get the complete analysis for FRA:PBS0

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.73
Price
€1.45
GF Value